Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015 (2015), Article ID 930249, 12 pages
http://dx.doi.org/10.1155/2015/930249
Research Article

Polypeptide Fraction from Arca subcrenata Induces Apoptosis and G2/M Phase Arrest in HeLa Cells via ROS-Mediated MAPKs Pathways

1Biotechnological Institute of Chinese Materia Medica, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
2Department of Pharmacology, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China
3School of Chemistry and Chemical Engineering, Guangdong Pharmaceutical University, 9-13 Changmingshui Avenue, Wuguishan District, Zhongshan 528458, China

Received 9 February 2015; Accepted 30 April 2015

Academic Editor: Shuang-En Chuang

Copyright © 2015 Xianjing Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Costa, C. B. S. Telles, R. M. Oliveira et al., “Heterofucan from Sargassum filipendula induces apoptosis in HeLa cells,” Marine Drugs, vol. 9, no. 4, pp. 603–614, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. G. Rose, “Chemoradiotherapy for cervical cancer,” European Journal of Cancer, vol. 38, no. 2, pp. 270–278, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. W.-H. Lee, J.-S. Choi, H. Y. Kim et al., “Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation,” Cancer Letters, vol. 294, no. 1, pp. 74–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. National Cancer Institute, Cancer Drug Information, National Cancer Institute, 2012, http://www.cancer.gov/cancertopics/druginfo/cytarabine.
  5. K. Petit and J.-F. Biard, “Marine natural products and related compounds as anticancer agents: an overview of their clinical status,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 4, pp. 603–631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Mutter and M. Wills, “Chemistry and clinical biology of the bryostatins,” Bioorganic & Medicinal Chemistry, vol. 8, no. 8, pp. 1841–1860, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Um, Y.-J. Kim, H. Kwon et al., “Sungsanpin, a lasso peptide from a deep-sea streptomycete,” Journal of Natural Products, vol. 76, no. 5, pp. 873–879, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Dyshlovoy, S. N. Fedorov, A. I. Kalinovsky et al., “Mycalamide A shows cytotoxic properties and prevents EGF-induced neoplastic transformation through inhibition of nuclear factors,” Marine Drugs, vol. 10, no. 6, pp. 1212–1224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L.-H. Zheng, Y.-J. Wang, J. Sheng et al., “Antitumor peptides from marine organisms,” Marine Drugs, vol. 9, no. 10, pp. 1840–1859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. H. Zheng, X. K. Lin, N. Wu et al., “Targeting cellular apoptotic pathway with peptides from marine organisms,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1836, no. 1, pp. 42–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. B. Ujiki, B. Milam, X.-Z. Ding et al., “A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest,” Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1224–1228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wang, B. Zhao, W. Zhang et al., “Mycoepoxydiene, a fungal polyketide, induces cell cycle arrest at the G2/M phase and apoptosis in HeLa cells,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 23, pp. 7054–7058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Boonstra and J. A. Post, “Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells,” Gene, vol. 337, pp. 1–13, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Y. Kim, J. M. An, W.-Y. Chung et al., “Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters,” Phytotherapy Research, vol. 27, no. 4, pp. 493–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-K. Lee and O. J. Park, “Soybean isoflavone genistein regulates apoptosis through NF-κB dependent and independent pathways,” Experimental and Toxicologic Pathology, vol. 65, no. 1-2, pp. 1–6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Wang, L. Yuan, H. F. Xiao, C. X. Xiao, Y. T. Wang, and X. Liu, “Momordin Ic induces HepG2 cell apoptosis through MAPK and PI3K/Akt-mediated mitochondrial pathways,” Apoptosis, vol. 18, no. 6, pp. 751–765, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Xu, Y. P. Ching, Y. Zhou, J. F. Chiu, F. Chen, and Q. Y. He, “Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells,” Journal of Proteomics, vol. 75, no. 2, pp. 491–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. R. Stadtman and B. S. Berlett, “Reactive oxygen-mediated protein oxidation in aging and disease,” Drug Metabolism Reviews, vol. 30, no. 2, pp. 225–243, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. D. N. Dhanasekaran and E. P. Reddy, “JNK signaling in apoptosis,” Oncogene, vol. 27, no. 48, pp. 6245–6251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Suzuki, R. Mizuno, K. Suenaga et al., “Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells,” Cancer Medicine, vol. 2, no. 1, pp. 32–39, 2013. View at Publisher · View at Google Scholar
  21. H. Depenbrock, R. Peter, G. T. Faircloth, I. Manzanares, J. Jimeno, and A. R. Hanauske, “In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells,” British Journal of Cancer, vol. 78, no. 6, pp. 739–744, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. K.-H. Lee, S. Nishimura, S. Matsunaga, N. Fusetani, S. Horinouchi, and M. Yoshida, “Inhibition of protein synthesis and activation of stress activated protein kinases by onnamide A and theopederin B, antitumor marine natural products,” Cancer Science, vol. 96, no. 6, pp. 357–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Wang, A. Wu, Y. Xu, J. Liu, and X. Qian, “M2-A induces apoptosis and G2-M arrest via inhibiting PI3 K/Akt pathway in HL60 cells,” Cancer Letters, vol. 283, no. 2, pp. 193–202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D.-O. Moon, M.-O. Kim, Y. H. Choi, J. W. Hyun, W. Y. Chang, and G.-Y. Kim, “Butein induces G2/M phase arrest and apoptosis in human hepatoma cancer cells through ROS generation,” Cancer Letters, vol. 288, no. 2, pp. 204–213, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. M. He, C. H. Liu, Y. X. Chen et al., “Isolation and structural characterization of a novel polysaccharide prepared from Arca subcrenata Lischke,” Journal of Bioscience and Bioengineering, vol. 104, no. 2, pp. 111–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. X. S. Guo and Y. Li, Marine Traditional Chinese Medicines, Sciences Press, Beijing, China, 2003.
  27. X. Q. Hu, H. J. Wu, Z. M. Lin, and X. P. Fan, “Preliminary study on physicochemical property of glycosaminoglycan from Arca subcrenata Lischke and its effects on immune organs of mice,” Modern Food Science Technology, vol. 24, no. 8, pp. 763–766, 2008. View at Google Scholar
  28. L. Y. Song, S. F. Ren, R. M. Yu, C. Y. Yan, T. F. Li, and Y. Zhao, “Purification, characterization and in vitro anti-tumor activity of proteins from Arca subcrenata Lischke,” Marine Drugs, vol. 6, no. 3, pp. 418–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Y. Song, T. F. Li, R. M. Yu, C. Y. Yan, S. F. Ren, and Y. Zhao, “Antioxidant activities of hydrolysates of Arca subcrenata prepared with three proteases,” Marine Drugs, vol. 6, no. 4, pp. 607–619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. X. J. Hu, L. Y. Song, L. J. Huang, Q. Zheng, and R. M. Yu, “Antitumor effect of a polypeptide fraction from Arca subcrenata in vitro and in vivo,” Marine Drugs, vol. 10, no. 12, pp. 2782–2794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Q. Tang, I. B. Jaganath, and S. D. Sekaran, “Phyllanthus spp. induces selective growth inhibition of PC-3 and mewo human cancer cells through modulation of cell cycle and induction of apoptosis,” PLoS ONE, vol. 5, no. 9, Article ID e12644, pp. 1–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Y. Cheng, C. G. Wang, H. Z. Liu et al., “A novel polypeptide extracted from Ciona savignyi induces apoptosis through a mitochondrial-mediated pathway in human colorectal carcinoma cells,” Clinical Colorectal Cancer, vol. 11, no. 3, pp. 207–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. H. Li, Y. B. Niu, H. J. Wu et al., “Modified apple polysaccharides could induce apoptosis in colorectal cancer cells,” Journal of Food Science, vol. 75, no. 8, pp. H224–H229, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt, “Apoptosis—the p53 network,” Journal of Cell Science, vol. 116, no. 20, pp. 4077–4085, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. W. R. Lee, S. C. Shen, H. Y. Lin, W. C. Hou, L. L. Yang, and Y. C. Chen, “Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca2+-dependent endonuclease,” Biochemical Pharmacology, vol. 63, no. 2, pp. 225–236, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-L. Yang, C.-S. Chen, W.-H. Chang et al., “Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata,” Cancer Letters, vol. 231, no. 2, pp. 215–227, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Michieli, M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol, “Induction of WAF1/CIP1 by a p53-independent pathway,” Cancer Research, vol. 54, no. 13, pp. 3391–3395, 1994. View at Google Scholar · View at Scopus
  38. W. H. Park, “The effect of MAPK inhibitors and ROS modulators on cell growth and death of H2O2-treated HeLa cells,” Molecular Medicine Reports, vol. 8, no. 2, pp. 557–564, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Chang and M. Karin, “Mammalian MAP kinase signalling cascades,” Nature, vol. 410, no. 6824, pp. 37–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. C.-C. Teng, H.-C. Kuo, H.-C. Cheng, T.-C. Wang, and C.-I. Sze, “The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK,” Toxicology and Applied Pharmacology, vol. 263, no. 1, pp. 73–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. H. M. Ellis and H. R. Horvitz, “Genetic control of programmed cell death in the nematode C. elegans,” Cell, vol. 44, no. 6, pp. 817–829, 1986. View at Publisher · View at Google Scholar · View at Scopus
  42. K.-M. Debatin and P. H. Krammer, “Death receptors in chemotherapy and cancer,” Oncogene, vol. 23, no. 16, pp. 2950–2966, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. X. M. Sun, M. MacFarlane, J. Zhuang, B. B. Wolf, D. R. Green, and G. M. Cohen, “Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis,” The Journal of Biological Chemistry, vol. 274, no. 8, pp. 5053–5060, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. M. R. Wilson, “Apoptotic signal transduction: emerging pathways,” Biochemistry and Cell Biology, vol. 76, no. 4, pp. 573–582, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. D. D. Newmeyer and S. Ferguson-Miller, “Mitochondria: Releasing power for life and unleashing the machineries of death,” Cell, vol. 112, no. 4, pp. 481–490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. J. M. Cummins, A. M. Jequier, and R. Kan, “Molecular biology of human male infertility: links with aging, mitochondrial genetics, and oxidative stress?” Molecular Reproduction and Development, vol. 37, no. 3, pp. 345–362, 1994. View at Publisher · View at Google Scholar · View at Scopus
  47. L. H. Shang, C. M. Li, Z. Y. Yang, D. H. Che, J. Y. Cao, and Y. Yu, “Luffa echinata Roxb. induces human colon cancer cell (HT-29) death by triggering the mitochondrial apoptosis pathway,” Molecules, vol. 17, no. 5, pp. 5780–5794, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-C. Chiu, J. Y.-F. Chen, K.-L. Lin et al., “P38 MAPK and NF-κB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced anti-proliferation and apoptosis of human hepatoma cells,” Cancer Letters, vol. 295, no. 1, pp. 92–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Zhang, J. S. Ruan, L. G. Yan et al., “Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells,” Molecules, vol. 17, no. 4, pp. 3736–3750, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. G. K. Schwartz and M. A. Shah, “Targeting the cell cycle: a new approach to cancer therapy,” Journal of Clinical Oncology, vol. 23, no. 36, pp. 9408–9421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Kawabe, “G2 checkpoint abrogators as anticancer drugs,” Molecular Cancer Therapeutics, vol. 3, no. 4, pp. 513–519, 2004. View at Google Scholar · View at Scopus
  52. S. X. Liu, W. R. Bishop, and M. Liu, “Differential effects of cell cycle regulatory protein p21WAF1/Cip1 on apoptosis and sensitivity to cancer chemotherapy,” Drug Resistance Updates, vol. 6, no. 4, pp. 183–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Zhang, S. S. Leonard, C. S. Huang, V. Vallyathan, V. Castranova, and X. Shi, “Role of reactive oxygen species and MAPKs in vanadate-induced G2/M phase arrest,” Free Radical Biology and Medicine, vol. 34, no. 10, pp. 1333–1342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. A. L. Gartel and A. L. Tyner, “Transcriptional regulation of the p21WAF1/CIP1 gene,” Experimental Cell Research, vol. 246, no. 2, pp. 280–289, 1999. View at Publisher · View at Google Scholar · View at Scopus